Neurology 1707 - Neurology Alert - Jul 01, 2013

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Physician Editor
Matthew Fink, MD
Interim Chair and Neurologist-in-Chief
Department of Neurology and Neuroscience
Weill Cornell Medical College
New York Presbyterian Hospital

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Peer Reviewer
M. Flint Beal, MD
Anne Parrish Titzel Professor
Department of Neurology and Neuroscience
Weill Cornell Medical Center

Assistant Editors
Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders
Weill Cornell Medical College

Claire Henchcliffe, MD, PhD
Associate Professor of Neurology and Neuroscience
Weill Cornell Medical College

Dara Jamieson, MD
Associate Professor of Clinical Neurology
Weill Cornell Medical College

Alan Z. Segal, MD
Associate Professor of Clinical Neurology
Weill Cornell Medical College

Author
Norman Latov, MD, PhD
Professor of Neurology and Neuroscience
Department of Neurology and the Brain and Mind Research Institute
Weill Cornell Medical College

Subjects:

  • Anti-LRP4 Myasthenia Gravis
  • Telemedicine vs Clinic Visits for Patients with Parkinson's Disease
  • "˜I See Your Pain''” Functional MR Imaging of Thermal Pain
  • Significant Heritable Component to Risk and Size of Intracerebral Hematoma
  • Spontaneous Dissections of the Vertebral Arteries and the Carotid Arteries have Different Clinical Presentations and Outcomes
  • Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy
  • Poor Sleep Quality May Predict Preclinical Alzheimer's Disease

Objectives:

  • discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • discuss the pathogenesis and treatment of pain
  • describe the basic science of brain function
  • discuss new information regarding new drugs for commonly diagnosed neurological conditions

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET.

Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; managing editor Neill Kimball ; Assistant editors Michael Rubin, MD, FRCP(C) and Alan Z. Segal, MD report no financial relationships relevant to this field of study.

Assistant editor Claire Henchcliffe, MD, PhD reports she is on the speakers bureau and advisory board for Allergan and Teva; speakers bureau for Boehringer-Ingelheim, GlaxoSmith-Kline, and Novartis; advisory board for Merz; and is a consultant for Gerson Lehman Group and Guidepoint Global.

Assistant editor Dara Jamieson, MD reports she is a retained consultant for Boehringer Ingelheim and Bayer, and is on the speakers bureau for Boehringer Ingelheim.

Author Norman Latov, MD, PhD has served a consultant to Grifols, Novartis, CSL Behring, Baxter Biotherapeutics, and Merck, and owns stock in Therapath LLC.

Copyright 2013 AHC Media. All rights reserved.